Tag - ADK

Markets

Echelon ups Diagnos PT to $1.55 (Canadian); maintains top pick

Echelon Capital Markets raised its price target for Diagnos (TSXV:ADK) to $1.55 (Canadian) from 95 cents after it signed a memorandum of understanding (MoU) for a potential worldwide distribution agreement for its CARA...

August 17, 2021

Markets

Echelon pegs DIAGNOS as Q2 “top picks portfolio”

Echelon Capital Markets added DIAGNOS (TSXV:ADK) to its second quarter “top picks portfolio.” Analyst Stefan Quenneville rates the stock as “speculative buy” with a price target of 85 cents. The stock was quoted at 53...

April 8, 2021

Markets

Echelon starts Diagnos at speculative buy; PT 85 cents (Canadian)

Echelon Capital Markets initiated coverage of Diagnos (TSXV:ADK) with a “speculative buy” rating and price target of 85 cents (Canadian). The stock closed at 60 cents on March 4. ADK is a commercial-stage artificial...

March 5, 2021

Tag - ADK

Echelon ups Diagnos PT to $1.55 (Canadian); maintains top pick

Echelon pegs DIAGNOS as Q2 “top picks portfolio”

Echelon starts Diagnos at speculative buy; PT 85 cents (Canadian)

General

More